1. Home
  2. WRBY vs PBLS Comparison

WRBY vs PBLS Comparison

Compare WRBY & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$26.87

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

SELL

Current Price

$27.85

Market Cap

3.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WRBY
PBLS
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
WRBY
PBLS
Price
$26.87
$27.85
Analyst Decision
Buy
Strong Buy
Analyst Count
13
6
Target Price
$31.00
★ $41.40
AVG Volume (30 Days)
★ 3.0M
1.1M
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 105.88
N/A
EPS
★ 0.06
N/A
Revenue
★ $871,905,000.00
N/A
Revenue This Year
$11.16
N/A
Revenue Next Year
$16.92
$300.17
P/E Ratio
$354.83
★ N/A
Revenue Growth
★ 13.04
N/A
52 Week Low
$16.26
$22.66
52 Week High
$31.00
$42.49

Technical Indicators

Market Signals
Indicator
WRBY
PBLS
Relative Strength Index (RSI) 31.20 54.57
Support Level $21.29 $26.42
Resistance Level $27.43 $33.65
Average True Range (ATR) 1.52 2.39
MACD -0.40 0.77
Stochastic Oscillator 1.84 94.25

Price Performance

Historical Comparison
WRBY
PBLS

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: